Divergent lineage of a novel hantavirus in the banana pipistrelle (Neoromicia nanus) in Côte d'Ivoire

Recently identified hantaviruses harbored by shrews and moles (order Soricomorpha) suggest that other mammals having shared ancestry may serve as reservoirs. To investigate this possibility, archival tissues from 213 insectivorous bats (order Chiroptera) were analyzed for hantavirus RNA by RT-PCR. Following numerous failed attempts, hantavirus RNA was detected in ethanol-fixed liver tissue from two banana pipistrelles (Neoromicia nanus), captured near Mouyassué village in Côte d'Ivoire, West Africa, in June 2011. Phylogenetic analysis of partial L-segment sequences using maximum-likelihood and Bayesian methods revealed that the newfound hantavirus, designated Mouyassué virus (MOUV), was highly divergent and basal to all other rodent- and soricomorph-borne hantaviruses, except for Nova virus in the European common mole (Talpa europaea). Full genome sequencing of MOUV and further surveys of other bat species for hantaviruses, now underway, will provide critical insights into the evolution and diversification of hantaviruses

Evolutionary Insights from a Genetically Divergent Hantavirus Harbored by the European Common Mole (Talpa europaea)

BACKGROUND:The discovery of genetically distinct hantaviruses in shrews (Order Soricomorpha, Family Soricidae) from widely separated geographic regions challenges the hypothesis that rodents (Order Rodentia, Family Muridae and Cricetidae) are the primordial reservoir hosts of hantaviruses and also predicts that other soricomorphs harbor hantaviruses. Recently, novel hantavirus genomes have been detected in moles of the Family Talpidae, including the Japanese shrew mole (Urotrichus talpoides) and American shrew mole (Neurotrichus gibbsii). We present new insights into the evolutionary history of hantaviruses gained from a highly divergent hantavirus, designated Nova virus (NVAV), identified in the European common mole (Talpa europaea) captured in Hungary. METHODOLOGY/PRINCIPAL FINDINGS:Pair-wise alignment and comparison of the full-length S- and L-genomic segments indicated moderately low sequence similarity of 54-65% and 46-63% at the nucleotide and amino acid levels, respectively, between NVAV and representative rodent- and soricid-borne hantaviruses. Despite the high degree of sequence divergence, the predicted secondary structure of the NVAV nucleocapsid protein exhibited the characteristic coiled-coil domains at the amino-terminal end, and the L-segment motifs, typically found in hantaviruses, were well conserved. Phylogenetic analyses, using maximum-likelihood and Bayesian methods, showed that NVAV formed a distinct clade that was evolutionarily distant from all other hantaviruses. CONCLUSIONS:Newly identified hantaviruses harbored by shrews and moles support long-standing virus-host relationships and suggest that ancestral soricomorphs, rather than rodents, may have been the early or original mammalian hosts

Hantavirus in Northern Short-tailed Shrew, United States

Phylogenetic analyses, based on partial medium- and large-segment sequences, support an ancient evolutionary origin of a genetically distinct hantavirus detected by reverse transcription–PCR in tissues of northern short-tailed shrews (Blarina brevicauda) captured in Minnesota in August 1998. To our knowledge, this is the first evidence of hantaviruses harbored by shrews in the Americas

A Strategy To Estimate Unknown Viral Diversity in Mammals

The majority of emerging zoonoses originate in wildlife, and many are caused by viruses. However, there are no rigorous estimates of total viral diversity (here termed “virodiversity”) for any wildlife species, despite the utility of this to future surveillance and control of emerging zoonoses. In this case study, we repeatedly sampled a mammalian wildlife host known to harbor emerging zoonotic pathogens (the Indian Flying Fox, Pteropus giganteus) and used PCR with degenerate viral family-level primers to discover and analyze the occurrence patterns of 55 viruses from nine viral families. We then adapted statistical techniques used to estimate biodiversity in vertebrates and plants and estimated the total viral richness of these nine families in P. giganteus to be 58 viruses. Our analyses demonstrate proof-of-concept of a strategy for estimating viral richness and provide the first statistically supported estimate of the number of undiscovered viruses in a mammalian host. We used a simple extrapolation to estimate that there are a minimum of 320,000 mammalian viruses awaiting discovery within these nine families, assuming all species harbor a similar number of viruses, with minimal turnover between host species. We estimate the cost of discovering these viruses to be ~$6.3 billion (or ~$1.4 billion for 85% of the total diversity), which if annualized over a 10-year study time frame would represent a small fraction of the cost of many pandemic zoonoses. IMPORTANCE Recent years have seen a dramatic increase in viral discovery efforts. However, most lack rigorous systematic design, which limits our ability to understand viral diversity and its ecological drivers and reduces their value to public health intervention. Here, we present a new framework for the discovery of novel viruses in wildlife and use it to make the first-ever estimate of the number of viruses that exist in a mammalian host. As pathogens continue to emerge from wildlife, this estimate allows us to put preliminary bounds around the potential size of the total zoonotic pool and facilitates a better understanding of where best to allocate resources for the subsequent discovery of global viral diversity

Reservoirs and vectors of emerging viruses

Wildlife, especially mammals and birds, are hosts to an enormous number of viruses, most of which we have absolutely no knowledge about even though we know these viruses circulate readily in their specific niches. More often than not, these viruses are silent or asymptomatic in their natural hosts. In some instances, they can infect other species, and in rare cases, this cross-species transmission might lead to human infection. There are also instances where we know the reservoir hosts of zoonotic viruses that can and do infect humans. Studies of these animal hosts, the reservoirs of the viruses, provide us with the knowledge of the types of virus circulating in wildlife species, their incidence, pathogenicity for their host, and in some instances, the potential for transmission to other hosts. This paper describes examples of some of the viruses that have been detected in wildlife, and the reservoir hosts from which they have been detected. It also briefly explores the spread of arthropod-borne viruses and their diseases through the movement and establishment of vectors in new habitats

Rooms for Tomorrow for the Rising Health Risks of Today: The Impact of Harm Reduction Facilities and Health Outcomes

The purpose of this paper is to analyze the effects of harm reduction facilities (HRF) on health outcomes for intravenous drug users (IDU). The types of HRFs that were taken into consideration for this paper were safe injection facilities (SIF) and needle exchange programs (NEP). People who inject drugs expose themselves to blood-borne diseases such as human immunodeficiency virus (HIV) and hepatitis C (HCV) when practicing unsafe risky needle sharing behaviors. Drug related deaths are on the rise and poses a major health crisis within our borders. Different public health methods and interventions are needed to address the IDU community health issues

EXAMINING STRUCTURAL RACISM AS A CAUSE OF HEALTH INEQUITIES AMONG PACIFIC ISLAND PEOPLES IN THE UNITED STATES AND AOTEAROA NEW ZEALAND: AN EXPLORATORY COMPARATIVE CASE STUDY

Native Hawaiians and Pacific Islanders (NHPI) in the United States are known to experience profound and persistent disparities across most indicators of socioeconomic status and health when compared to the majority population. Similarly, the Indigenous Māori and Pacific peoples in Aotearoa New Zealand parallel the same experiences. Reducing disparities and improving health equity among racial/ethnic minority populations have been regarded as a national priority in both the United States and New Zealand. Improved population health data have provided insights into the social determinants of health (SDoH), which has unveiled multiple factors that contribute to health disparities, including income, education, residential segregation, stress, social and physical environment, employment, and many others. Health disparities also represent a lack of efficiency within the health system. There is an increasing recognition to “dig deeper” and understand the root causes of inequities and examine the structural factors. More explicitly, how structural racism underlies the persistence of health disparities and inequities. Structural racism is defined as the macrolevel systems, social forces, institutions, ideologies, and processes that interact with one another to generate and reinforce inequities among racial and ethnic groups. Prior research and literature suggest that structural racism exists through the evidence of racial disparities. However, verification and understanding the scope of structural racism can only be done by asking those affected about their lived experiences. The focus of the study was to examine the extent to which structural racism is a fundamental cause of the health inequities and disparities among Pacific Islanders in the United States and New Zealand. Using a mixed-methods comparative design, a document analysis of publicly available resources (N=28) and key informant interviews (N=27) were conducted to assess the patterns of health inequities and disparities among Pacific Islanders and to understand the possible explanations through multiple contexts. The results of the analysis used in this study conceptualized the ways structural racism is operationalized. The study illustrates the experiences and forces that impact Pacific Islanders and offers insights into the wider historical and socio-political context of how structural racism affects Indigenous health. It also provides analyses of current public health practices in the United States and New Zealand